NEJM Publishes Final Results from Phase Two Study Showing Vaccines Can Reduce Rate of Sustained TB Infections
Trial offers hope for new revaccination strategies with Bacille Calmette-Guerin (BCG) against Tuberculosis, the world's leading infectious disease killer